Form 8-K - Current report:
SEC Accession No. 0001140361-25-015880
Filing Date
2025-04-28
Accepted
2025-04-28 07:05:24
Documents
38
Period of Report
2025-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048044_8k.htm   iXBRL 8-K 31742
2 EXHIBIT 99.1 ef20048044_ex99-1.htm EX-99.1 54264
6 GRAPHIC ef20048044_ex99-1slide1.jpg GRAPHIC 72300
7 GRAPHIC ef20048044_ex99-1slide2.jpg GRAPHIC 365305
8 GRAPHIC ef20048044_ex99-1slide3.jpg GRAPHIC 135974
9 GRAPHIC ef20048044_ex99-1slide4.jpg GRAPHIC 189999
10 GRAPHIC ef20048044_ex99-1slide5.jpg GRAPHIC 142912
11 GRAPHIC ef20048044_ex99-1slide6.jpg GRAPHIC 184629
12 GRAPHIC ef20048044_ex99-1slide7.jpg GRAPHIC 160672
13 GRAPHIC ef20048044_ex99-1slide8.jpg GRAPHIC 149210
14 GRAPHIC ef20048044_ex99-1slide9.jpg GRAPHIC 115216
15 GRAPHIC ef20048044_ex99-1slide10.jpg GRAPHIC 177394
16 GRAPHIC ef20048044_ex99-1slide11.jpg GRAPHIC 158134
17 GRAPHIC ef20048044_ex99-1slide12.jpg GRAPHIC 144868
18 GRAPHIC ef20048044_ex99-1slide13.jpg GRAPHIC 180629
19 GRAPHIC ef20048044_ex99-1slide14.jpg GRAPHIC 193176
20 GRAPHIC ef20048044_ex99-1slide15.jpg GRAPHIC 219264
21 GRAPHIC ef20048044_ex99-1slide16.jpg GRAPHIC 91749
22 GRAPHIC ef20048044_ex99-1slide17.jpg GRAPHIC 147848
23 GRAPHIC ef20048044_ex99-1slide18.jpg GRAPHIC 62641
24 GRAPHIC ef20048044_ex99-1slide19.jpg GRAPHIC 195428
25 GRAPHIC ef20048044_ex99-1slide20.jpg GRAPHIC 137942
26 GRAPHIC ef20048044_ex99-1slide21.jpg GRAPHIC 173877
27 GRAPHIC ef20048044_ex99-1slide22.jpg GRAPHIC 173219
28 GRAPHIC ef20048044_ex99-1slide23.jpg GRAPHIC 150838
29 GRAPHIC ef20048044_ex99-1slide24.jpg GRAPHIC 66166
  Complete submission text file 0001140361-25-015880.txt   5460735

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gyre-20250428.xsd EX-101.SCH 4024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gyre-20250428_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gyre-20250428_pre.xml EX-101.PRE 16072
41 EXTRACTED XBRL INSTANCE DOCUMENT ef20048044_8k_htm.xml XML 4205
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 25875922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)